Metabolomics-derived prostate cancer biomarkers: Fact or fiction?

Journal of Proteome Research

Volumn 14, Issue 3, 2015, Pages 1455-1464

  Kumar, Deepak ^a,c   Gupta, Ashish ^a   Mandhani, Anil ^a   Sankhwar, Satya Narain ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c DR A P J ABDUL KALAM TECHNICAL UNIVERSITY   (India)

Author keywords

NMR spectroscopy; OPLS DA; PCA; prostate cancer; serum metabolomics

Indexed keywords

ALANINE; GLYCINE; PYRUVIC ACID; SARCOSINE; TUMOR MARKER;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; METABOLOMICS; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; AGED; METABOLISM; MIDDLE AGED; PROSTATE TUMOR;

AGED; BIOMARKERS, TUMOR; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 84924371152     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5011108     Document Type: Article

References (20)

1. Pal, R. P.; Maitra, N. U.; Mellon, J. K.; Khan, M. A. Defining prostate cancer risk before prostate biopsy Urol. Oncol. 2013, 31 (8) 1408-1418
2. Mitka, M. Is PSA testing still useful? J. Am. Med. Assoc 2004, 292 (19) 2326-2327
3. Thompson, I. M.; Pauler, D. K.; Goodman, P. J.; Tangen, C. M.; Lucia, M. S.; Parnes, H. I. Prevalence of prostate cancer among men with a prostate specific antigen level < or =4.0 ng per milliliter N Engl. J. Med. 2004, 350, 2239-2246
4. Bangma, C. H.; Roemeling, S.; Schroder, F. H. Over-diagnosis and over-treatment of early detected prostate cancer World J. Urol 2007, 25, 3-9
5. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457, 910-914
6. Thysell, E.; Surowiec, I.; Hornberg, E. Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol PLoS One 2010, 5, e14175
7. Bansal, N.; Gupta, A.; Mitash, N. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach J. Proteome Res. 2013, 12, 5839-5890
8. 1H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma Clin. Chim. Acta 2015, 441, 47-55
9. Jentzmik, F.; Stephan, C.; Miller, K. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumors Eur. Urol. 2010, 58, 12-18
10. Jentzmik, F.; Stephan, C.; Lein, M. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression J. Urol. 2011, 185, 706-711
11. Walsh, M. C.; Brennan, L.; Malthouse, J. P. G.; Roche, H. M.; Gibney, M. J. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans Am. J. Clin. Nutr. 2006, 84, 531-539
12. Vigneau-Callahan, K. E.; Shestopalov, A. I.; Milbury, P. E.; Matson, W. R.; Kristal, B. S. Characterization of diet-dependent metabolic serotypes: Analytical and biological variability issues in rats J. Nutr. 2001, 131, 924S-932S
13. Lucarelli, G.; Fanelli, M.; Larocca, A. M. V. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0ng/mL Prostate 2012, 72, 1611-1621
14. Putluri, N.; Shojaie, A.; Vasu, V. T. metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells PLoS One 2011, 6 (7) e21417
15. 1H HR-MAS spectroscopy of biopsy tissues Magn. Reson. Med. 2008, 60, 510-516
16. Costello, L. C.; Franklin, R. B. 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis Mol. Cell. Biochem. 2005, 280, 1-8
17. Moreadith, R. W.; Lehninger, A. L. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme J. Biol. Chem. 1984, 259, 6215-6221
18. 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading Cancer Res. 2008, 68 (20) 8607-8615
19. Khan, A. P.; Rajendiran, T. M.; Ateeq, B. The role of sarcosine in prostate cancer progression Neoplasia 2013, 15, 491-501
20. Grebe, S. K. G.; Singh, R. J. LC-MS/MS in the clinical laboratory - where to from here? Clin. Biochem. Rev. 2011, 32, 5-31